Adipose tissue dysfunction and its effects on tumor metabolism

Area of Science:

• Oncology
• Metabolic Research
• Cell Biology

Background:

• Obesity is a growing global health concern, linked to increased risks of diabetes, metabolic syndrome, and various cancers.
• Obesity negatively impacts cancer patient outcomes, correlating with higher recurrence rates and chemoresistance.
• Adipocytes (fat cells) are metabolically active, influencing tumor microenvironments through secreted factors.

Purpose of the Study:

• To examine how adipocyte-derived factors regulate malignant cell metabolism within the tumor niche.
• To elucidate the relationship between obesity and cancer, focusing on metabolic alterations.
• To review current literature on adipose-tumor cell interactions and their impact on cancer metabolism.

Main Methods:

• Literature review of studies investigating obesity, cancer, and cellular metabolism.
• Analysis of signaling pathways involved in metabolic regulation within tumor cells.
• Examination of adipokine and cytokine roles in altering tumor microenvironments.

Main Results:

• Obesity promotes a shift in tumor cell metabolism towards increased glycolysis and hypoxia, often via the Warburg effect.
• Key signaling pathways like phosphoinositol-3 kinase (PI3K), hypoxia-inducible factor-1 alpha (HIF-1α), and c-MYC are implicated in mediating these metabolic changes.
• Adipocyte-derived factors contribute to the altered metabolic state of cancer cells, influencing tumor progression.

Conclusions:

• Adipose tissue actively influences cancer progression by altering tumor cell metabolism.
• Understanding these metabolic changes is crucial for developing targeted cancer therapies.
• Further research into the interplay between obesity and cancer metabolism can lead to improved treatment strategies.